4534 related articles for article (PubMed ID: 6451350)
1. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
2. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
3. [Immunotherapy of breast cancer (review of foreign literature)].
Liapis MA
Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
[No Abstract] [Full Text] [Related]
4. Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy.
Mathé G; Florentin I; Olsson L; Bruley-Rosset M; Schulz J; Kiger N; Orbach-Arbouys S; Schwarzenberg L; Pouillart P; de Vassal F
Cancer Treat Rep; 1978 Nov; 62(11):1613-21. PubMed ID: 103616
[TBL] [Abstract][Full Text] [Related]
5. Combination chemo-immunotherapy with adriamycin in experimental tumor systems.
Tagliabue A; Polentarutti N; Vecchi A; Mantovani A; Spreafico F
Eur J Cancer (1965); 1977 Jul; 13(7):657-65. PubMed ID: 598392
[No Abstract] [Full Text] [Related]
6. [Immunotherapy today. II. Immunostimulating therapy].
D'Amelio R
Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of malignant diseases. A way towards the goal?].
Riethmüller G
MMW Munch Med Wochenschr; 1978 Feb; 120(6):161-2. PubMed ID: 305530
[No Abstract] [Full Text] [Related]
8. Biologic response modifiers as adjuncts to other therapeutic modalities.
Borden EC; Hawkins MJ
Semin Oncol; 1986 Jun; 13(2):144-52. PubMed ID: 2424086
[No Abstract] [Full Text] [Related]
9. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
Mathé G
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
[No Abstract] [Full Text] [Related]
10. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
Theilen GH; Hills D
J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
[No Abstract] [Full Text] [Related]
11. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A
Bibl Haematol; 1970; (36):678-88. PubMed ID: 5293620
[No Abstract] [Full Text] [Related]
12. Immunotherapy of solid tumor.
Holmes EC
Surg Clin North Am; 1979 Apr; 59(2):371-80. PubMed ID: 375448
[No Abstract] [Full Text] [Related]
13. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
14. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
Mathé G; Kamel M; Dezfulian M; Halle-Pannenko O; Bourut C
Cancer Res; 1973 Sep; 33(9):1987-97. PubMed ID: 4146853
[No Abstract] [Full Text] [Related]
15. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].
Saggese V; Zanda G
Minerva Pediatr; 1974 Jun; 26(21):1087-93. PubMed ID: 4526571
[No Abstract] [Full Text] [Related]
16. [Current trends in immunotherapy of tumors of the lung].
Crispano G; Toglia V; Tranchese D; Schettini R
Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
[No Abstract] [Full Text] [Related]
17. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
Mathe G; Amiel JL; Schwarsenberg L; Hyat M; Pouillart P; Schenider M; Cattan A; Jasmin C; Belpomme D; Schulmberger JR; De Vassal F; Musset M; Misset JL
Folia Clin Int (Barc); 1975 Mar; 25(3):131-51. PubMed ID: 1056311
[No Abstract] [Full Text] [Related]
18. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
19. Immunostimulation: synthetic and biological modulators of immunity.
Fudenberg HH; Whitten HD
Annu Rev Pharmacol Toxicol; 1984; 24():147-74. PubMed ID: 6203479
[No Abstract] [Full Text] [Related]
20. Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.
Mathé G; Schwarzenberg L; Halle-Pannenko O; Simmler MC
Ann N Y Acad Sci; 1976; 277(00):467-84. PubMed ID: 826207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
